News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

Online Dating Sites: The Size of the Potential Dating Pool Makes all the Difference
News Release

BALTIMORE, MD, September 11, 2024 – Online dating sites have become one of the more popular means for people to meet each other and explore the potential for a romantic relationship. But did you know that it’s the size of the online dating pool that could make or break your own quest for love?

Read More
Presidential election chaos drives early holiday shopping
Media Coverage

Blame the presidential election for extra early Christmas shopping this year.

Read More
Sheldon H. Jacobson: Is artificial intelligence for the birds? More than you may think.
Media Coverage

The test for any breakthrough technology is often where you least expect it, but once it “conquers” that application, even more possibilities may emerge.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Digital Tool Helps Hospital Make Important Coronavirus Retest Decisions

Digital Tool Helps Hospital Make Important Coronavirus Retest Decisions

Georgia Tech News Center, April 13, 2020

What-if questions can torment a doctor making coronavirus retest decisions: What if a patient’s initial negative test was a false negative, and he or she needs a second test? What if they don’t need it, and a retest would use up a scarce test kit and treatments that other patients need?

Fast Coronavirus Test Gets Emergency FDA Approval

Fast Coronavirus Test Gets Emergency FDA Approval

Tech News World, March 31, 2020

Abbott will deliver 50,000 COVID-19 tests per day to healthcare workers, starting Wednesday, using its modified ID NOW testing process, it said. Bringing rapid coronavirus testing capacity to the medical front lines is crucial in the battle to flatten the rising death and infection curve worldwide.

In rare move, Gilead gives up 'orphan' status for experimental coronavirus drug

In rare move, Gilead gives up 'orphan' status for experimental coronavirus drug

Biopharmadive, March 25, 2020

Gilead has asked the Food and Drug Administration to rescind a special regulatory status for its experimental coronavirus drug, but not before stirring up a controversy that had critics accusing the company of manipulating a law designed to spur research into therapies for rare diseases.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine